eGenesis, Inc. Full-time
operating company Β· company profileNew York Β· 2 people tracked
Investment thesis
eGenesis addresses organ transplant scarcity through cross-species transplantation enabled by advanced genome engineering. The firm has built a porcine platform with targeted genetic edits to mitigate retroviral risk and achieve immunologic and molecular compatibility with human recipients, aiming to eliminate transplant waitlists and reduce mortality.
Source: firm website, verified Aug 6, 2026.
Team Β· 2 people
from the firm's website & public directories
Frequently asked questions
- What sectors does eGenesis, Inc. Full-time focus on?
- eGenesis, Inc. Full-time focuses on Biotech, Deep Tech, Medical Devices.
- Where is eGenesis, Inc. Full-time located?
- eGenesis, Inc. Full-time is headquartered in New York, US.
Images
Similar investors
ACT Venture Capital is an independent Irish venture capital firm that invests β¬1 million to β¬15 million in growth-stage private companies, with capacity for larger commitments through syndicated rounds.
Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Canaan Partners is a venture capital firm with over 30 years of history, backing companies across technology and healthcare sectors through close, hands-on partnerships with founders.
Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.